The Company plans to conduct medical research and clinical trials to develop Cannabinoids-based pharmaceuticals and treatments for conditions including, but not limited to, psoriasis, fibromyalgia, PTSD, Depression, Anxiety and migraines.
and then this (could be huge)
The Company will also be pursuing the "Recreational Market" in Canada with expansion plans into the USA once the proper legal standards are addressed.
News 
Market Data 
Discover 
